The NFL has strongly supported the Philadelphia Eagles’ management of quarterback Jalen Hurts’s blood clot situation, with the players’ union subsequently calling for an inquiry into the matter. A credible source revealed that the Eagles faced no disciplinary action concerning their actions with Hurts. The NFL’s chief medical officer, Dr. Allen Sills, passionately defended the Eagles’ approach to treating Hurts, emphasizing the team’s cautious and patient-centered care throughout the process. The NFL Players Association has stated that they were informed by the league that no review was planned, emphasizing the need for a thorough investigation to ensure the highest level of care for players in the future.
Hurts, currently on injured reserve, is projected to miss the remainder of the season due to a blood clot in his left calf that migrated to his lungs, resulting in deep vein thrombosis and bilateral pulmonary embolisms. NFL executive vice president Jeff Miller refuted reports of Hurts going without sleep for an extended period before playing, asserting that Hurts had slept for approximately seven to eight hours. Dr. Caron Rockman, a vascular surgeon, commended the Eagles for their handling of the situation, describing it as a judgment call based on individual circumstances.
Moving forward, Hurts’s treatment will involve blood thinners, and he will be sidelined from football activities until he is off them. The incident occurred when Hurts played in London against Jacksonville after being diagnosed with a left calf superficial vein thrombosis. Dr. Sills reiterated that decisions regarding Hurts were prioritized based on medical considerations over football, emphasizing the medical team’s commitment to player safety.